We have applied genomic, computational, and molecular approaches towards understanding basic mechanisms of nuclear receptor biology and their impact on human diseases. Our research has focused on estrogen receptors (ERs)and their role in breast cancer, and we have utilized microarrays, binding site modeling, and chromatin immunoprecipitation (ChIP) to study transcriptional regulatory mechanisms and gene expression profiles associated with disease outcomes in patient samples. Using the experimental approaches and tools developed and refined in our studies of estrogen receptors, we look to expand our efforts towards characterizing other nuclear receptors and their roles in biological and pathogenic processes.
Our research is currently funded by the NIH and start-up funds from CNRCS.Bajic, V.B., Tan, S.L., Chong, A., Tang, S., Strom, A.,
Gustafsson, J.- Å., Lin, C.-Y., and
Liu, E.T. Dragon ERE Finder ver. 2.0: A tool for accurate detection of estrogen
response elements in vertebrate genomes. Nucleic Acid Res 2003; 31(13):3605-07.
Vega, V.B., Bangarusamy, D.K., Miller, L.D., Liu, E.T., and Lin, C.-Y. BEARR: Batch extraction and
analysis of cis-regulatory regions. Nucleid Acid Res. 2004; 32 Web Server
Issue: W257-60.
*Lin, C.-Y.,
Strom, A., Vega, V.B., Kong, S.L., Thomsen J.S., Yeo, A.L., Doray, B., Chan,
W.C., Bangarusamy, D.K., Tang, S., Chong, A., Bajic, V.B., Ramasamy, A.,
Vergara, L., Miller, L.D., Gustafsson, J.- Å., and Liu, E.T. Discovery of estrogen receptor a target genes and response elements
in breast tumor cells. Genome Biology
2004; 5 (9):R66. *Designated as a Highly Accessed article by BioMed Central.
Reid, G., Metivier, R., Lin,
C.-Y., Ibberson, D., Denger, S., Brand, H., Liu, E.T., and Gannon, F. Multiple mechanisms induce transcriptional
silencing of a subset of genes, including oestrogen receptor alpha, in response
to deacetylase inhibition by valproic acid and trichostatin A. Oncogene
2005; 24 (31):4894-907.
Hall, P., Ploner, A., Bjohle, J., Huang, F., Lin, C.-Y., Liu, E.T., Miller, L.D.,
Pawitan, Y., Shaw, P., Skoog, L., Smeds, J., Wedren, S, Ohd, J., and Bergh, J. Postmenopausal
hormone replacement therapy represses gene expression in human breast
cancer. BMC Med. 2006; 4:16.
Frasor, J., Chang, E., Komm, B., Lin, C.-Y., Liu, E.T., Miller, L.D., Bergh, J., Smeds, J., and
Katzenellenbogen, B.S. Gene expression preferentially regulated by Tamoxifen in
breast cancer cells and correlations with clinical response. Cancer Res. 2006;
Jul 15; 66(14):7334-40.
Su, X., Lin, C.-Y.; O'Shea, S. J., Teh, H. F.,
Peh, W. Y. X., and Thomsen, J. S. Combinational
Application of Surface Plasmon Resonance Spectroscopy and Quartz Crystal
Microbalance for Studying Nuclear Hormone Receptor-Response Element
Interactions. Anal. Chem. 2006; Aug 1;78(15):5552-8.
*Vega, V.B., *Lin, C.-Y., Lai, K.S., Kong, S.L., Xie, M.,
Su, X., The, H.F., Thomsen, J.S., Yeo, A.L., Sung, W.K., Bourque, G., Liu, E.T.
Multi-platform genome-wide identification and modeling of functional human
estrogen receptor binding sites. Genome Biol. 2006;7(9):R82. *Shared first
authorship and designated as a Highly Accessed article by BioMed Central.
Nilsson, M, Stulnig, T.M., Lin C.-Y., Yeo, A.L., Nowotny, P., Liu,
E.T., and Steffensen, K.R. Liver X receptors regulate adrenal steroidogenesis
and hypothalamic-pituitary-adrenal feedback. Mol. Endo., 2007; 21(1):126-137.
*Lin, C.-Y.,
Strom, A., Kong, S.L., Kietz, S., Thomsen, J.S., Tee, J.B.S., Vega, V.B.,
Miller, L.D., Johanna Smeds, Jonas Bergh, Gustafsson, J.- Å., and Liu, E.T. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res., 2007; 9(2):R25. *Designated as
a Highly Accessed article by BioMed Central.
*Lin, C.-Y., *Vega,
V.B., Thomsen, J.S., Zhang, T., Kong, S.L., Xie, M., Chiu, K.P., Lipovich, L.,
Barnett, D.H., Stossi, F., Yeo, A., George, J., Kuznetsov, V.A., Lee, Y.K.,
Charn, T.H., Palanisamy, N., Cheung, E., Katzenellenbogen, B.S., Miller, L.D.,
Ruan, Y., Bourque, G., Wei, C.L., and Liu, E.T. Whole-genome Cartography of
Estrogen Receptor a Binding Sites. PLOS
Genetics 2007, 3(6):e87. *Shared first authorship.
Denger, S., Bahr-Ivacevic, T., Brand, H., Reid, G., Blake,
J., Seifert, M., Lin, C.-Y., May,
K., Benes, V., Liu, E.T., and Gannon, F. Transcriptome profiling of
estrogen-regulated genes in human primary osteoblasts reveals an osteoblast
specific regulation of the IGFBP4 gene. Mol. Endo. 2008, 22(2):361-79.
Barnett, D.H., Sheng, S., Charn, T.-H., Waheed, A, Sly,
W.S., Lin, C.-Y., Liu, E.T., and
Katzenellenbogen, B.S. Estrogen Receptor Regulation of the Carbonic Anhydrase
XII (CA12) Gene Through a Distal Enhancer. Cancer Res. 2008, 68(9):3505-15.
Müller, P., Merrell, K.W., Crofts, J.D., Ronnlund, C., Lin, C.-Y., Gustafsson, J.-Å., and
Ström, A. Estrogen-dependent downregulation of HES-1 gene expression in breast
cancer cells is mediated via a 3 distal element. J. Endo. 2009, 200(3):311-19.
Müller, P.,Crofts, J.D., Newman, B.S., Bridgewater, L.C., Lin, C.-Y., Gustafsson, J.-Å., and Ström, A. SOX9 mediates the
retinoic acid-induced HES-1 gene expression in human breast cancer cells.
Breast Can. Res. Treat. 2009, Mar. 26, [Epub ahead of print].
Frasor, J., Weaver, A., Pradhan, M., Dai, Y., Miller, L.D., Lin, C.-Y., Stanculescu, A. and
Positive Crosstalk between Estrogen Receptor and NF-kB in Breast Cancer. Cancer
Res. 2009, 69(23):8918-25.
Comments